Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« House Bans Forcing Meds on Kids | Main | Neurons Love to "Kiss and Run" »

June 3, 2003

Punctuated Cognition

Email This Entry

Posted by Zack Lynch

Have you ever suddenly realized that you’re routinely doing complex tasks that flummoxed you a few years ago? That’s what it feels like to cross a cognitive threshold.


According to organizational psychologist Elliot Jaques, who died in March, skills and capabilities seem to accumulate through a kind of punctuated equilibrium, wherein human ability to deal with complexity crosses a cognitive threshold every 15 years.


It will be interesting to see how the emergence of cogniceuticals will influence this observed rule. 


(Thanks to Art Kleiner and Ross Mayfield for bringing this to my attention.)

Comments (0) | Category: Cogniceuticals



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives